Explore the challenges and successes epilepsy centers face in implementing the newly expanded NAEC guidelines, particularly regarding mental health screenings and multidisciplinary care.
Explore the challenges and successes epilepsy centers face in implementing the newly expanded NAEC guidelines, particularly regarding mental health screenings and multidisciplinary care.
Discover how the new 2023 Guidelines for epilepsy centers highlight comprehensive care and the pivotal role of genetic testing in addressing health disparities and improving patient outcomes.
Discover how the new 2023 Guidelines for epilepsy centers highlight comprehensive care and the pivotal role of genetic testing in addressing health disparities and improving patient outcomes.
Dr Ivanhoe examines why she doesn't typically use oral medications for patients with spasticity, how to naviagate effective communication between clinician and patient, exciting new treatments on the horizon, and how not to lose "that human...
Dr Ivanhoe examines why she doesn't typically use oral medications for patients with spasticity, how to naviagate effective communication between clinician and patient, exciting new treatments on the horizon, and how not to lose "that human...
Dr Ivanhoe discusses everything from treatment variations between pediatric and adult patients to botulinum neurotoxin use and the nuanced factors influencing candidate selection to the profound impact of untreated spasticity on long-term...
Dr Ivanhoe discusses everything from treatment variations between pediatric and adult patients to botulinum neurotoxin use and the nuanced factors influencing candidate selection to the profound impact of untreated spasticity on long-term...
In Part 2 of this Q&A, Scott Otallah, MD, describes some of the challenges providers can expect to face when treating MS in pediatric patients as well as trends to keep an eye on in the near future.
In Part 2 of this Q&A, Scott Otallah, MD, describes some of the challenges providers can expect to face when treating MS in pediatric patients as well as trends to keep an eye on in the near future.
The presence of frontal release signs (FRS), primitive reflexes that reemerge with neurodegeneration or brain injury, may help identify older adults at increased risk for future cognitive decline, according to a cohort study.
The presence of frontal release signs (FRS), primitive reflexes that reemerge with neurodegeneration or brain injury, may help identify older adults at increased risk for future cognitive decline, according to a cohort study.
A multicenter randomized clinical trial found that reperfusion-guided systolic blood pressure (BP) management after successful endovascular therapy improved 90-day functional outcomes compared with guideline-recommended care.
A multicenter randomized clinical trial found that reperfusion-guided systolic blood pressure (BP) management after successful endovascular therapy improved 90-day functional outcomes compared with guideline-recommended care.
SKY-0515, an investigational oral RNA splicing modifier, reduced mutant huntingtin (mHTT) protein levels in blood by up to 69% and PMS1 mRNA by up to 26% in a phase 1/2 Huntington’s disease (HD) trial.
SKY-0515, an investigational oral RNA splicing modifier, reduced mutant huntingtin (mHTT) protein levels in blood by up to 69% and PMS1 mRNA by up to 26% in a phase 1/2 Huntington’s disease (HD) trial.
In a South Korea–based multicenter cohort, plasma phosphorylated tau217 (p-tau217), glial fibrillary acidic protein (GFAP), and neurofilament light chain (NfL) were associated with cognitive decline in early-onset Alzheimer disease (EOAD).
In a South Korea–based multicenter cohort, plasma phosphorylated tau217 (p-tau217), glial fibrillary acidic protein (GFAP), and neurofilament light chain (NfL) were associated with cognitive decline in early-onset Alzheimer disease (EOAD).
Findings from a large Aspirin in Reducing Events in the Elderly (ASPREE) cohort suggest cognitive changes could serve as early indicators of cardiovascular risk.
Findings from a large Aspirin in Reducing Events in the Elderly (ASPREE) cohort suggest cognitive changes could serve as early indicators of cardiovascular risk.
The addition of endovascular treatment (EVT) to best medical treatment (BMT) was associated with a higher likelihood of achieving good imaging outcomes compared with BMT alone in patients with a medium or distal vessel occlusion stroke.
The addition of endovascular treatment (EVT) to best medical treatment (BMT) was associated with a higher likelihood of achieving good imaging outcomes compared with BMT alone in patients with a medium or distal vessel occlusion stroke.
Real-world data presented at the American Academy of Neurology (AAN) 2026 Annual Meeting reported improvements in migraine-related cognitive symptoms with eptinezumab (VYEPTI).
Real-world data presented at the American Academy of Neurology (AAN) 2026 Annual Meeting reported improvements in migraine-related cognitive symptoms with eptinezumab (VYEPTI).
Teleneurological ward rounds were found noninferior to conventional on-site ward rounds in subacute inpatient stroke care, according to prospective study findings.
Teleneurological ward rounds were found noninferior to conventional on-site ward rounds in subacute inpatient stroke care, according to prospective study findings.
High-dose influenza vaccination may confer additional neuroprotective benefit beyond standard-dose formulations, according to results from a new, large retrospective cohort study published in Neurology.
High-dose influenza vaccination may confer additional neuroprotective benefit beyond standard-dose formulations, according to results from a new, large retrospective cohort study published in Neurology.
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
To view accreditation information/faculty disclosures for the program, click
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
To view accreditation information/faculty disclosures for the program, click
